Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Gawin (1988)
Chronic neuropharmacology of cocaine: progress in pharmacotherapy.The Journal of clinical psychiatry, 49 Suppl
J. Volpicelli, A. Alterman, M. Hayashida, C. O'brien (1992)
Naltrexone in the treatment of alcohol dependence.Archives of general psychiatry, 49 11
H. Rosen, A. Flemenbaum, Slater Vl (1986)
Clinical trial of carbidopa-L-dopa combination for cocaine abuse.The American journal of psychiatry, 143 11
Thomas Brown, P. Seraganian, Jacques Tremblay (1993)
Alcohol and cocaine abusers 6 months after traditional treatment: do they fare as well as problem drinkers?Journal of substance abuse treatment, 10 6
P. Johnson, J. Neyman (1936)
Tests of certain linear hypotheses and their application to some educational problems.
D. Regier, M. Farmer, D. Rae, B. Locke, S. Keith, L. Judd, F. Goodwin (1990)
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.JAMA, 264 19
D. Pfohl, J. Allen, R. Atkinson, D. Knopman, R. Malcolm, J. Mitchell, J. Morley (1986)
Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage.NIDA research monograph, 67
J. Vry, I. Donselaar, J. Ree (1989)
Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol.The Journal of pharmacology and experimental therapeutics, 251 2
M. Waldrop (1989)
NIDA aims to fight drugs with drugs.Science, 245 4925
M. Bohn, D. Krahn, B. Staehler (1995)
Development and initial validation of a measure of drinking urges in abstinent alcoholics.Alcoholism, clinical and experimental research, 19 3
H. Kranzler, R. Escobar, Duk‐Ki Lee, E. Meza (1996)
Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers.Alcoholism, clinical and experimental research, 20 1
N. Mello, J. Mendelson, Bree Mp, S. Lukas (1990)
Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys.The Journal of pharmacology and experimental therapeutics, 254 3
Charles O'Brien, Childress Ar, I. Arndt, Mclellan At, G. Woody, I. Maany (1988)
Pharmacological and behavioral treatments of cocaine dependence: controlled studies.The Journal of clinical psychiatry, 49 Suppl
S. O'Malley, A. Jaffe, G. Chang, R. Schottenfeld, R. Meyer, B. Rounsaville (1992)
Naltrexone and coping skills therapy for alcohol dependence. A controlled study.Archives of general psychiatry, 49 11
E. Gehan (1965)
A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.Biometrika, 52
T. Kosten, H. Kleber, C. Morgan (1989)
Role of opioid antagonists in treating intravenous cocaine abuse.Life sciences, 44 13
B. Mason, E. Ritvo, R. Morgan, F. Salvato, G. Goldberg, B. Welch, E. Mantero-Atienza (1994)
A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol DependenceAlcoholism: Clinical and Experimental Research, 18
H. Ross, F. Glaser, T. Germanson (1988)
The prevalence of psychiatric disorders in patients with alcohol and other drug problems.Archives of general psychiatry, 45 11
S. Higgins, A. Budney, Warren Bickel, J. Hughes, F. Foerg, G. Badger (1993)
Achieving cocaine abstinence with a behavioral approach.The American journal of psychiatry, 150 5
C. Dackis, M. Gold (1985)
BROMOCRIPTINE AS TREATMENT OF COCAINE ABUSEThe Lancet, 325
M. Bohn, H. Kranzler, Despina Beazoglou, B. Staehler (1994)
Naltrexone and Brief Counseling to Reduce Heavy DrinkingAmerican Journal on Addictions, 3
V. Modesto-Lowe, J. Burleson, D. Hersh, L. Bauer, H. Kranzler (1997)
Effects of naltrexone on cue-elicited craving for alcohol and cocaine.Drug and alcohol dependence, 49 1
H. Kranzler, Joseph Burleson, F. Boca, Thomas Babor, P. Korner, Joseph Brown, M. Bohn (1994)
Buspirone treatment of anxious alcoholics. A placebo-controlled trial.Archives of general psychiatry, 51 9
J. Volpicelli, K. Rhines, J. Rhines, L. Volpicelli, A. Alterman, C. O'brien (1997)
Naltrexone and alcohol dependence. Role of subject compliance.Archives of general psychiatry, 54 8
H. Kranzler, Judith Stone, Lynn McLaughlin (1995)
Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable.Drug and alcohol dependence, 40 1
F. Boca, H. Kranzler, J. Brown, P. Korner (1996)
Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.Alcoholism, clinical and experimental research, 20 8
K. Carroll, D. Ziedonis, S. O'Malley, E. McCance-Katz, L. Gordon, B. Rounsaville (1993)
Pharmacologic Interventions for Alcohol- and Cocaine-Abusing Individuals: A Pilot Study of Disulfiram vs. NaltrexoneAmerican Journal on Addictions, 2
S. Tiffany, E. Singleton, C. Haertzen, J. Henningfield (1993)
The development of a cocaine craving questionnaire.Drug and alcohol dependence, 34 1
M. Hesselbrock, R. Meyer, J. Keener (1985)
Psychopathology in hospitalized alcoholics.Archives of general psychiatry, 42 11
M. Sobell, A. Cooper, S. Maisto, TERRI Cooper, L. Sobell, Barbara Sanders (1980)
Developing a Prototype for Evaluating Alcohol Treatment Effectiveness
Naltrexone (NTX) has been shown to be efficacious for the treatment of alcohol dependence. Since alcohol and cocaine use disorders commonly co-occur, we conducted a randomized, double-blind, placebo-controlled trial of NTX 50 mg/day in 64 subjects with comorbid alcohol and cocaine use disorders. Although subjects in both groups reduced their consumption of both alcohol and cocaine during the 8-week trial, there was no consistent advantage to NTX over placebo treatment. We conclude that, due to behavioral, neurochemical, or other factors, individuals with both alcohol and cocaine use disorders are distinct from those dependent on alcohol alone, and that NTX at a dosage of 50 mg/day is not efficacious in this patient population. Several factors, including medication dosage, length of treatment, sample size and attrition rate, limit the interpretation of these findings. Consequently, we recommend that subsequent trials of NTX to reduce the risk of relapse in patients with comorbid alcohol and cocaine use disorders take these issues into account.
Psychopharmacology – Springer Journals
Published: Sep 1, 1998
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.